Gould Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.1K Buy
412
+115
+39% +$10.2K 0.02% 100
2025
Q4
$23.5K Hold
297
0.01% 114
2025
Q3
$23.7K Hold
297
0.01% 113
2025
Q2
$27K Hold
297
0.02% 103
2025
Q1
$27.8K Buy
297
+30
+11% +$2.69K 0.02% 97
2024
Q4
$24.3K Hold
267
0.02% 112
2024
Q3
$27.7K Hold
267
0.02% 109
2024
Q2
$25.9K Buy
267
+4
+2% +$369 0.02% 112
2024
Q1
$23.7K Hold
263
0.02% 115
2023
Q4
$21K Buy
263
+6
+2% +$451 0.02% 123
2023
Q3
$18.2K Hold
257
0.01% 118
2023
Q2
$19.8K Hold
257
0.02% 116
2023
Q1
$19.3K Buy
257
+26
+11% +$1.93K 0.01% 120
2022
Q4
$18.2K Buy
231
+4
+2% +$300 0.01% 123
2022
Q3
$16K Hold
227
0.01% 119
2022
Q2
$18K Buy
227
+4
+2% +$313 0.01% 112
2022
Q1
$17K Buy
223
+5
+2% +$396 0.01% 129
2021
Q4
$19K Buy
+218
New +$17K 0.01% 130

Other funds holding CL

Gould Capital's CL Position: Q1 2026 in Review

Gould Capital increased its Colgate-Palmolive (CL) stake by 39% in Q1 2026, buying an estimated $10.2K and bringing the position to 412 shares worth $35.1K. The position accounts for 0.02% of the portfolio, ranked #100.

Gould Capital first reported a position in CL in Q4 2021 and has held it in 18 quarters since. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Gould Capital held 412 shares of Colgate-Palmolive worth $35.1K as of Q1 2026.
  • Gould Capital bought 115 Colgate-Palmolive shares in Q1 2026, an estimated $10.2K.
  • Colgate-Palmolive made up 0.02% of Gould Capital's portfolio in Q1 2026, its #100 holding.
  • Gould Capital first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 18 quarters since.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Gould Capital's 13F filing for Q1 2026, filed 18 May 2026.